IVF Refund Program vs. Loan vs. Payment Plan: Break-Even Math on a $28K Cycle Using Your Own Success Odds

You just got a financing offer that sounds generous. Maybe it's a shared-risk package with a refund if you don't take home a baby. Maybe it's a loan with a monthly payment that looks manageable. Maybe it's a clinic payment plan at 0% for twelve months. The hard question is one nobody at the front desk can answer for you: which of these is actually cheaper for your odds?

The answer changes with your age, your diagnosis, and your clinic's real numbers. It can flip from one patient to the next inside the same clinic. This post gives you the math so you can run it yourself.

One note before we start. Every dollar figure and probability below is a worked example I constructed, not a quote from a clinic and not SART data. Swap in your own numbers. The structure of the calculation is the useful part.

Why "risk transfer" always has a price

A story from Healthcare Dive helps here. Ascension sells ownership in Arizona Medicaid plan to Aetna describes a deal that lets Ascension shed insurance risk while Aetna takes a stake in the plan. The lesson isn't about fertility. When one party hands risk to another, the receiving party prices that risk in. Nobody absorbs uncertainty for free.

A shared-risk IVF program works the same way. The clinic takes on the risk that you won't have a baby after several cycles, and you pay a higher upfront fee for that. Whether that's a good trade depends on how likely you are to need the protection. A patient with a high chance per cycle is mostly paying for insurance they won't use. A patient with a low chance may be buying something worth more than its price. That is the whole game, and we can put numbers on it.

Step 1: Pin down what one cycle really costs

Clinic quotes usually cover the clinic's own fee. Medications, monitoring, genetic testing, and the frozen transfer often sit outside it. For a full breakdown, see why medications, PGT-A, and monitoring add $12K-$20K to any clinic quote.

For our example, one cycle looks like this:

Component	Example cost
Clinic fee (retrieval, lab, embryo culture)	$15,000
Medications	$6,000
Monitoring, PGT, and frozen transfer	$7,000
All-in per cycle	$28,000

Keep the split between the first row and the other two in mind. Shared-risk programs often cover the first row and leave the others to you. That detail matters a lot in the math below.

Step 2: Turn your success rate into cumulative odds

This is where most people get stuck, and it's the step SART tables make hard. The number you need is your per-cycle live birth probability, meaning the chance that one retrieval and its transfers end in a live birth. Your clinic's published number for your age band, plus your diagnosis, gets you to a working estimate. If you want help reading those tables, start with how to read SART clinic data by age.

Here are three example patients. The per-cycle probabilities are assumptions for illustration only:

Example patient	Per-cycle chance (p)	After 1 cycle	After 2 cycles	After 3 cycles
A: lower odds	15%	15.0%	27.8%	38.6%
B: middle odds	25%	25.0%	43.8%	57.8%
C: higher odds	40%	40.0%	64.0%	78.4%

The formula is 1 − (1 − p)ⁿ, where n is the number of cycles. It treats each cycle as an independent try, which is a simplification. Real cycles aren't perfectly independent, and some people stop for reasons that have nothing to do with results. Even so, it's the right first-pass tool.

One number in that table changes how you should think about money. Patient B, at 25% per cycle, has a 57.8% chance after three cycles. That means a 42.2% chance of paying for three cycles and not having a baby. Not seeing a baby after three cycles is emotionally brutal, and it's a real financial scenario you should price in advance. It says nothing about how hard you tried.

Step 3: The three ways people pay

Path 1: Pay per cycle with a loan. You borrow for each cycle and pay it back over time. At an example 10% APR over 60 months, a $28,000 loan runs about $595 a month and roughly $7,700 in interest. At an example 15% APR, it's about $666 a month and roughly $12,000 in interest. Your rate depends on your credit, so treat both as placeholders.

Path 2: Clinic payment plan. Some clinics split the cost into installments. At 0% over 12 months, $28,000 is about $2,333 a month. It's cheap in interest terms and hard on monthly cash flow. Ask what happens to your balance if you cancel or change plans midstream.

Path 3: Shared-risk or refund program. You pay one larger fee that covers up to a set number of cycles and receive a partial or full refund if you don't have a live birth. For our example: $42,000 upfront for the clinic fees on up to three cycles, with a 70% refund ($29,400) if none succeeds. Medications, monitoring, and PGT ($13,000 per cycle) are still billed to you.

For a deeper look at these three side by side, see the shared-risk vs. loan vs. payment plan break-even math after a failed cycle.

This is the kind of side-by-side Feralyx is built for. You can run your own age, clinic, and cost inputs through it instead of building the spreadsheet yourself.

The worked example: expected spend for each patient

Assume each patient plans up to three cycles and stops at the first live birth. The expected number of cycles is 1 + (1 − p) + (1 − p)², since you only pay for the next cycle if the last one didn't work.

Pay-per-cycle expected spend is $28,000 times expected cycles.

Shared-risk expected spend has three parts:

The $42,000 program fee, minus the expected refund. The refund is $29,400 times the chance all three cycles fail, (1 − p)³.
Plus $13,000 in meds, monitoring, and PGT for each cycle you actually do.

Here are the results:

Patient	Expected cycles	Pay-per-cycle	Shared-risk (net of expected refund)	Cheaper option
A (15%)	2.57	$72,030	$57,387	Shared-risk, by about $14,600
B (25%)	2.31	$64,750	$59,659	Shared-risk, by about $5,100
C (40%)	1.96	$54,880	$61,130	Pay-per-cycle, by about $6,250

To see where a row comes from, take Patient B:

Expected cycles: 1 + 0.75 + 0.5625 = 2.3125
Pay-per-cycle: 2.3125 × $28,000 = $64,750
Chance all three fail: 0.75³ = 0.4219
Expected refund: 0.4219 × $29,400 = $12,403
Net program fee: $42,000 − $12,403 = $29,597
Per-cycle extras: 2.3125 × $13,000 = $30,063
Shared-risk total: $29,597 + $30,063 = $59,660

The break-even point

Set the two totals equal and solve. Under these example prices, the crossover lands at a per-cycle live birth chance of about 31%. Below that, the refund program comes out cheaper in expectation. Above it, paying per cycle wins.

That number is specific to this fee, this refund percentage, and this split of costs. If your program charges $50,000 or refunds 50%, the break-even moves. The direction is what carries over: a refund program is worth more the lower your odds, and worth less the higher your odds.

If you'd rather find your own break-even than trust mine, you can model this for your specific situation at Feralyx.

The catch: programs screen for the people who need them least

You may be wondering why anyone with a 15% chance would be offered a refund program at all. Often they aren't. Shared-risk programs usually set eligibility rules based on age, ovarian reserve, and diagnosis. The patients who need the protection most may be the ones the program declines to cover. Every "expected savings" calculation depends on being accepted first.

Before you sign, get answers in writing to these questions:

How does the contract define success? Live birth, positive pregnancy test, or something else? Does it require a baby to be born at a specific gestational age?
What is the refund percentage, and on what base? A 70% refund of clinic fees is a very different number from 70% of everything you paid.
What's excluded? Meds, PGT, monitoring, and frozen transfers are the usual suspects. Multiply anything excluded by every cycle you might do.
What happens on a cancelled cycle? A cycle stopped before retrieval may or may not count as one of your "covered" cycles. This matters because cancellation rates can hide a clinic's true outcomes. See how cancellation rates distort SART comparisons.
What are the qualifying tests, and who pays for them? A program can look cheap until the testing bill arrives.
What if you stop early? Circumstances change. Life, health, and your mind can too. Find out what leaving after cycle 1 or 2 costs you.

None of this is a judgment about whether to enter such a program. It's a question of whether the contract does what the marketing implies.

The stacking problem nobody puts in the loan ad

Loans look manageable one at a time. IVF rarely happens one time. Here is what happens to a monthly budget when cycles follow each other, using the 10% APR example ($595 a month per $28,000 borrowed):

Situation	Loan payments per month
Cycle 1 loan only	about $595
Cycle 1 not successful, cycle 2 borrowed	about $1,190
Cycle 2 not successful, cycle 3 borrowed	about $1,785

If Patient B's odds hold, there's a 75% chance of needing a second loan and a 56% chance of needing a third. Total interest also compounds across those loans. Three loans at the 10% example rate add up to roughly $23,100 in interest, on $84,000 borrowed. That's a big reason a program's upfront fee can look expensive while still costing less overall.

Loans do have an upside the program doesn't. If cycle 1 works, you stop borrowing and you keep the flexibility. A prepaid program spends money before you know whether you'll need the later cycles. Your cash position matters as much as your probability. A $42,000 upfront fee is a real barrier for many families.

What the health-policy headlines mean for your financing plan

Several recent KFF Health News stories aren't about fertility at all. Read together, they point at something your financing plan has to account for: coverage and cost rules are less stable than they look.

Sticker Shock at the Doctor's Office Could Motivate Midterm Voters notes that steep jumps in health insurance premiums and deductibles are top of mind for voters heading into the midterms. If your plan's deductible or premium changes at renewal, that affects any IVF-adjacent costs your plan does cover, such as diagnostics, monitoring, and some medications. Timing a cycle around a plan year can change your out-of-pocket total. For the coverage side, see why you can't trust your benefits portal.
Cost-Saving Medicaid Meal Deliveries Threatened by Cuts, Policy Uncertainty reports that budget cuts could lead states to rethink benefits, and that one state already has. The takeaway isn't that IVF is affected. It's that a benefit that exists this year may not exist next year, so don't build a three-cycle financing plan on a benefit you haven't confirmed in writing.
The Drugs and Devices Have Been on the Market for Years. But FDA-Ordered Studies Still Aren't Done. reports that the FDA lets companies run safety or efficacy studies after approval, and that many of those studies are behind schedule or overdue. It isn't about fertility drugs specifically. I'd read it as a general prompt. If an add-on to your cycle is priced as an extra and you'd borrow at interest to pay for it, ask your clinic what the evidence is for your situation. That's a question for your doctor, not a financial one, but it does move your budget.

A short worksheet you can use tonight

Do this before you sign anything:

Get the all-in per-cycle cost in writing. Include meds, monitoring, PGT, and the first frozen transfer.
Find your per-cycle live birth rate. Use your clinic's SART numbers for your age band, then adjust for your diagnosis with your doctor.
Compute your cumulative odds at 1, 2, and 3 cycles using 1 − (1 − p)ⁿ.
Price each path: loan (monthly payment and total interest), payment plan (monthly cash flow), program (fee, refund percentage, exclusions).
Find your break-even. If your per-cycle odds are well above it, pay-per-cycle probably wins. If they're well below it and you qualify, the refund program is worth a closer look.
Stress-test the bad outcome. Ask what you'd owe if all three cycles fail, and whether you could carry that.

For the head-to-head with real program structures, our post on shared-risk refund programs vs. pay-per-cycle walks through a $35K program against a $28K cycle.

The bottom line

Quoted price is only the first number. What decides the best financing route is your all-in cycle cost, your per-cycle probability, and the fine print in the refund contract. In the example above, the refund program was cheaper in expectation for two of three patients and more expensive for the third, and the break-even sat near 31%. Yours will land somewhere else.

None of that math makes the emotional side easier. Deciding how to pay for another attempt after one that didn't work is exhausting, and it's fine to want the numbers before you decide. Comparing clinics and financing options with your own age, diagnosis, insurance, and location is the step most people skip because building the spreadsheet is a lot. If you'd like help with it, start at Feralyx and run your numbers before you commit to another cycle.

Sources

Health Journalists Visit Conservative Georgia District and Weigh AI Bioweapon Threat — KFF Reproductive Health
The Drugs and Devices Have Been on the Market for Years. But FDA-Ordered Studies Still Aren’t Done. — KFF Reproductive Health
Ascension sells ownership in Arizona Medicaid plan to Aetna — Healthcare Dive
Cost-Saving Medicaid Meal Deliveries Threatened by Cuts, Policy Uncertainty — KFF Reproductive Health
Sticker Shock at the Doctor’s Office Could Motivate Midterm Voters — KFF Reproductive Health